DeSantis Robert - 15 Feb 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Product Officer
Signature
By: Donna Spinola For: DeSantis, Robert
Issuer symbol
ISRG
Transactions as of
15 Feb 2023
Transactions value $
-$637,574
Form type
4
Filing time
16 Feb 2023, 17:45:32 UTC
Previous filing
30 Jan 2023
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $0 +2.12K +30.88% $0.00 9K 15 Feb 2023 Direct F1
transaction ISRG Common Stock Tax liability -$163K -666 -7.4% $244.77 8.34K 15 Feb 2023 Direct F1
transaction ISRG Common Stock Sale -$475K -1.97K -23.64% $240.77 6.37K 16 Feb 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Restricted Stock Units Options Exercise $0 -2.12K -100% $0.00* 0 15 Feb 2023 Common Stock 2.12K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F2 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.
F3 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.